Aspen gets regulatory nod in Brazil and SA for generic injectable semaglutide

Move follows strong sales of Mounjaro and growing GLP-1 market interest

Aspen gets regulatory nod in Brazil and SA for generic injectable semaglutide
Move follows strong sales of Mounjaro and growing GLP-1 market interest